CoChat

Dual targeting of Notch and Wnt/β‐catenin pathways: Potential approach in triple‐negative breast cancer treatment

Nasser, Fatma, Moussa, Nermine, Helmy, Maged W., Haroun, Medhat · 2021 · Naunyn-Schmiedeberg s Archives of Pharmacology

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Abstract

Despite the continuously growing repertoire of new and improved anti-cancer therapies, triple-negative breast cancer (TNBC) remains a clinical challenge to treat. In this sense, targeting signaling pathways such as Notch and Wnt/β-catenin have attracted growing attention. This work aimed at investigating the possible antitumor effects of IMR-1 as a Notch inhibitor, PRI-724 as a Wnt/β-catenin inhibitor, as well as their combination and to explore the possible crosstalk between Notch and Wnt/β-catenin signaling pathways in MDA-MB-231 TNBC cell line. Microculture tetrazolium test (MTT) was used to determine the drug growth inhibition (GI50), and the results were analyzed using CompuSyn 3.0.1 software. MDA-MB-231 cells were divided into four treatment groups including positive control, IMR-1-treated, PRI-724-treated, and combination-treated groups. Sandwich enzyme-linked immunosorbent assay (ELISA) was used for the determination of the protein levels of hairy and enhancer of split-1 (HES-1), Notch-1, β-catenin, cyclin-D1, and vascular endothelial growth factor (VEGF1). HES-1 gene expression was assessed by quantitative real-time polymerase chain reaction. Statistical analyses were performed using GraphPad Prism Software. The GI50 for IMR-1 and PRI-724 were 15.3 μM and 0.69 μM, respectively. Upon treatment of MDA-MB-231 cells with these drugs, HES-1 gene expression was up-regulated due to single and combined treatments. Moreover, the protein levels of cyclin-D1, VEGF1, HES-1, and Notch-1 were reduced, while those of active β-catenin and active caspase-3 were elevated. IMR-1/PRI-724 combination augmented IMR-1- and PRI-724-mediated effects on MDA-MB-231 cells by initiating apoptotic cell death. Further in vitro and in vivo studies are warranted to support our findings.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00210-020-01988-x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Dang TP (2012) Notch, apoptosis and cancer BT - notch signaling in embryology and cancer. In: Reichrath J, Reichrath S (eds) Advances in experimental medicine and biology. Springer US, New York, pp 199–209

Cited by

See all 29

Metadata

Authors
Nasser, F., Moussa, N., Helmy, M. W., & Haroun, M.
Affiliations
  • Alexandria University (EG)
  • Damanhour University (EG)
Corresponding author
Moussa, Nermine
Venue
Naunyn-Schmiedeberg s Archives of Pharmacology
Published
2020-10-14
Volume
394
Issue
3
Pages
481-490
ISSN
  • 0028-1298 (ISSN-L)
  • 1432-1912
OpenAlex
W3092285135
Cited by
29
References
40
Citations by year
2026: 7 · 2025: 9 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 2
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
triple-negative breast cancer, Notch signaling, Wnt/β-catenin signaling, PRI-724, combination therapy, Hes1, Notch1, cyclin D1, apoptosis, MDA-MB-231 cells, signaling crosstalk
MeSH terms
Transcription Factor HES-1, Antineoplastic Agents, Drug Interactions, Humans, Pyrimidinones, Apoptosis, Bridged Bicyclo Compounds, Heterocyclic, Cyclin D1, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Cell Proliferation, beta Catenin, Receptor, Notch1, Caspase 3, Thiazolidines, Wnt Signaling Pathway, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.